###begin article-title 0
###xml 62 65 <span type="species:ncbi:9606">Men</span>
Altered PI3-Kinase/Akt Signalling in Skeletal Muscle of Young Men with Low Birth Weight
###end article-title 0
###begin p 1
Conceived and designed the experiments: CBJ HS SM AV SEO. Performed the experiments: CBJ MSMG HS. Analyzed the data: CBJ MSMG. Contributed reagents/materials/analysis tools: CBJ MSMG SEO. Wrote the paper: CBJ MSMG SEO.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 218 221 <span type="species:ncbi:9606">men</span>
###xml 526 529 <span type="species:ncbi:9606">men</span>
Low birth weight (LBW) is associated with increased future risk of insulin resistance and type 2 diabetes mellitus. The underlying molecular mechanisms remain poorly understood. We have previously shown that young LBW men have reduced skeletal muscle expression of PI3K p85alpha regulatory subunit and p110beta catalytic subunit, PKCzeta and GLUT4 in the fasting state. The aim of this study was to determine whether insulin activation of the PI3K/Akt and MAPK signalling pathways is altered in skeletal muscle of young adult men with LBW.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 91 93 91 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 73 76 <span type="species:ncbi:9606">men</span>
Vastus lateralis muscle biopsies were obtained from 20 healthy 19-yr old men with BW</ = 10th percentile for gestational age (LBW) and 20 normal birth weight controls (NBW), matched for physical fitness and whole-body glucose disposal, prior to (fasting state) and following a 4-hr hyperinsulinemic euglycemic clamp (insulin stimulated state). Expression and phosphorylation of selected proteins was determined by Western blotting.
###end p 5
###begin title 6
Principal Findings
###end title 6
###begin p 7
###xml 102 105 <span type="species:ncbi:9606">men</span>
Insulin stimulated expression of aPKCzeta (p<0.001) and Akt1 (p<0.001) was decreased in muscle of LBW men when compared to insulin stimulated controls. LBW was associated with increased insulin stimulated levels of IRS1 (p<0.05), PI3K p85alpha (p<0.001) and p110beta (p<0.05) subunits, while there was no significant change in these proteins in insulin stimulated control muscle. In addition LBW had reduced insulin stimulated phospho-Akt (Ser 473) (p<0.01), indicative of reduced Akt signalling. Insulin stimulated expression/phosphorylation of all the MAPK proteins studied [p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182), phospho-ERK (Thr 202/Tyr204), JNK1, JNK2 and phospho-JNK (Thr 183/Tyr185)] was not different between groups.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 184 187 <span type="species:ncbi:9606">men</span>
We conclude that altered insulin activation of the PI3K/Akt but not the MAPK pathway precedes and may contribute to development of whole-body insulin resistance and type 2 diabetes in men with LBW.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 237 240 237 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Gluckman1">[1]</xref>
###xml 391 394 391 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-McMillen1">[2]</xref>
Developmental programming is the concept whereby nutritional or environmental stimuli, acting during critical windows in development, may have a lasting impact on cellular structure and function, and consequently, on patterns of disease [1]. Low birth weight (LBW), a surrogate marker of an adverse fetal environment, is associated with development of insulin resistance and type 2 diabetes [2]. However, the underlying molecular mechanisms remain poorly understood.
###end p 11
###begin p 12
###xml 81 84 81 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-DeFronzo1">[3]</xref>
###xml 167 170 167 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Martin1">[4]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Kensara1">[5]</xref>
###xml 327 330 327 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen1">[6]</xref>
###xml 595 598 595 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Hermann1">[7]</xref>
###xml 694 697 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne1">[8]</xref>
###xml 438 441 <span type="species:ncbi:9606">men</span>
Skeletal muscle accounts for the majority of insulin-stimulated glucose disposal [3], and defects in muscle insulin action represent an early marker for diabetes risk [4]. Healthy individuals with LBW have reduced muscle mass [5] and have recently been demonstrated to have altered fibre composition in vastus lateralis muscle [6], implying a role for skeletal muscle in the pathogenesis of insulin resistance in LBW. Moreover, young LBW men with normal glucose tolerance and normal whole-body glucose disposal have reduced forearm (muscle) glucose uptake following acute local insulin infusion [7] and decreased fasting expression of key insulin signalling proteins in vastus lateralis muscle [8], further supporting this concept.
###end p 12
###begin p 13
###xml 589 592 589 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Taniguchi1">[9]</xref>
###xml 841 844 828 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne1">[8]</xref>
###xml 1176 1180 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Koistinen1">[10]</xref>
###xml 1182 1186 1169 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Zarubin1">[11]</xref>
###xml 1220 1224 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Miller1">[12]</xref>
###xml 1287 1290 1274 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Taniguchi1">[9]</xref>
###xml 1370 1374 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Furtado1">[13]</xref>
###xml 1474 1478 1461 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Koistinen1">[10]</xref>
###xml 1685 1689 1672 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Lee1">[14]</xref>
###xml 1816 1819 1803 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Taniguchi1">[9]</xref>
###xml 634 637 <span type="species:ncbi:9606">men</span>
###xml 1465 1473 <span type="species:ncbi:9606">patients</span>
Insulin signalling is mediated by a highly complex network controlling a variety of different processes. Briefly, in the presence of insulin, the insulin receptor phosphorylates insulin receptor substrate (IRS) proteins, which are linked to the activation of two main signalling pathways: the metabolic phosphatidylinositol 3 kinase (PI3K)/ protein kinase B (Akt, also known as PKB) pathway, responsible for most of insulin's metabolic actions, and the mitogenic Ras-mitogen-activated protein kinase (MAPK) pathway, which is involved in mediating cell growth, survival and differentiation [9]. We have previously shown that young LBW men have reduced skeletal muscle expression of PI3K p85alpha regulatory subunit and p110beta catalytic subunit, atypical protein kinase C zeta (aPKCzeta) and glucose transporter (GLUT4) in the fasting state [8]. These changes precede the development of whole body insulin resistance and glucose intolerance. However, it remains to be determined whether the adverse fetal environment leads to alterations in the expression of proteins in MAPK signalling pathway. Insulin can activate three major members of the MAPK family, including p38 MAPK [10], [11], c-jun NH2-terminal kinase (JNK) [12] and extracellular signal-regulated kinase 1/2 (ERK1 and ERK2) [9]. Studies have indicated that p38 MAPK is required for full GLUT4 translocation [13] and aberrant p38 MAPK signalling in skeletal muscle has been described in type 2 diabetic patients [10]. JNK activity is increased in insulin-resistant states such as obesity and inflammation and can negatively regulate insulin signalling through serine phosphorylation of IRS-1 and impaired activation of Akt [14]. ERK1 and ERK2 may also be involved in a negative feedback loop of insulin action by phosphorylating IRS-1 on serine residues [9].
###end p 13
###begin p 14
###xml 211 217 <span type="species:ncbi:9606">humans</span>
###xml 268 271 <span type="species:ncbi:9606">men</span>
Thus, the goal of this study was to determine whether altered insulin activation of the PI3K/Akt and MAPK signalling pathways could contribute to the development of insulin resistance and type 2 diabetes in LBW humans. To that end, we recruited 20 healthy 19 year old men with LBW and 20 normal birth weight (NBW) controls. All subjects had normal glucose tolerance and whole-body insulin sensitivity and were matched for physical fitness. Muscle biopsies were obtained prior to and following a 4-hour hyperinsulinemic euglycemic clamp and expression, and phosphorylation of key insulin signaling proteins was determined by Western blotting.
###end p 14
###begin title 15
Materials and Methods
###end title 15
###begin title 16
Subjects and study protocol
###end title 16
###begin p 17
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen2">[15]</xref>
###xml 981 982 977 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1016 1020 1012 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen2">[15]</xref>
###xml 1267 1268 1263 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1327 1328 1323 1324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1461 1465 1457 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen2">[15]</xref>
###xml 16 19 <span type="species:ncbi:9606">men</span>
###xml 194 197 <span type="species:ncbi:9606">men</span>
###xml 268 271 <span type="species:ncbi:9606">men</span>
###xml 370 382 <span type="species:ncbi:9606">participants</span>
###xml 486 498 <span type="species:ncbi:9606">participants</span>
###xml 798 810 <span type="species:ncbi:9606">participants</span>
Forty singleton men born at term (39-41 weeks) in 1980 in Copenhagen County were recruited from the Danish Medical Birth Registry according to birth weight, as previously described [15]. Twenty men had birth weights </ = the 10th percentile (LBW: 2702+/-202 g) and 20 men had birth weights in the upper normal range (NBW: 50-75th percentile) (3801+/-101 g). None of the participants had a family history of diabetes (parents, grandparents), hypertension, or ischemic heart disease. All participants had normal glucose tolerance, as assessed by standard 75-gram OGTT, according to World Health Organization criteria. Subjects meeting these criteria were included consecutively and we made no specific attempts to match groups for body composition etc. Written informed consent was provided from all participants and approval was obtained from the regional ethics committee. All subjects had DEXA assessment of body composition and assessment of aerobic fitness using a submaximal VO2max test, as previously described [15]. On the study day, following a 24 hr standardized diet and exercise protocol, a 2-hr basal period and a standard 30-min intravenous glucose tolerance test, all subjects underwent a 4-hr two-step hyperinsulinemic euglycemic clamp (2 hrs at 10 mU/m2/min (low peripheral hyperinsulinemia) and 2 hrs at 40 mU/m2/min (prandial-like hyperinsulinemia) in combination with tritiated glucose tracer and indirect calorimetry, as previously described [15]. Muscle biopsies were excised at the end of the basal (+2 hrs after initiation of study) and insulin-stimulated steady state period (+4 hrs after initiation of insulin infusion).
###end p 17
###begin title 18
Muscle Biopsies
###end title 18
###begin p 19
Percutaneous muscle biopsies were obtained from the vastus lateralis muscle during local anaesthesia using a Bergstrom needle. Samples were blotted free of blood, connective tissue and visible fat, snap-frozen in liquid nitrogen and stored at -80degreesC until further analysis.
###end p 19
###begin title 20
Western blotting
###end title 20
###begin p 21
Muscle biopsies were extracted in ice-cold lysis buffer [50 mmol/l HEPES (pH 8), 150 mmol/l sodium chloride, 1% Triton X100, 1 mmol/l sodium orthovanadate, 30 mmol/l sodium fluoride, 10 mmol/l sodium pyrophosphate, 10 mmol/l EDTA and a protease inhibitor cocktail]. The total protein concentration in the lysates was determined using a Sigma copper/bicinchoninic assay. Protein content of muscle tissue did not differ between any of the groups. Samples were diluted to a common concentration of 1 mg/ml in Laemmli buffer and 20 ug total protein was subjected to SDS-PAGE. The proteins were transferred to PVDF Immobilon-P (Millipore) membrane, blocked for 1 hr (5% nonfat dehydrated milk, 1xTBS, 0.1% Tween 20), followed by overnight incubation with antibody against IRS-1 and PI3K p85alpha (Upstate Biotechnology, Lake Placid, USA); Akt1, Akt2, phospho-Akt (Ser473) (all Cell Signalling Technology, Beverly, USA); PKCzeta, PI3K p110beta (Santa Cruz Biotechnology, Santa Cruz, USA), phospho-ERK1/2 (Thr202/Tyr204), p38 MAP-kinase, phospho-p38 MAP-kinase (Thr180/Tyr182), JNK1, JNK2 (all Cell Signalling Technology, Beverly, USA); phospho-JNK (Thr183/Tyr185) and GLUT4 (both Abcam, Cambridge, UK) diluted in TBS-0.1% Teen 20 containing 5% dried milk or 5% BSA. Protein expression was quantified densitometrically using AlphaEase software (AlphaInnotech, San Leandro, USA). 20 microg and 10 microg of one sample was loaded onto each gel in order to ensure the linearity of the signal and to act as an inter-gel control.
###end p 21
###begin p 22
Due to the limited size of the biopsy two strategies were used to analyse protein expression. The first strategy was used for the analysis of proteins that have not been previously analysed under basal conditions: IRS-1, Akt2, phospho-Akt, p38 MAPK, phospho-p38 MAPK, JNK1, JNK2, phospho-JNK, phospho-ERK1. Three gels were used for the analysis of each protein, each gel containing six samples randomly chosen from the four study groups. For the analysis of PI3K p85alpha, PI3K p110beta, PKCzeta, Akt1 and GLUT4, which have been analysed under basal conditions previously, insulin-stimulated NBW and LBW muscle samples were run on two gels alongside 6 basal NBW samples (mean % control +/-1 STD) chosen on the basis of the previous study (8). For each antibody, control blots were performed in which varying amounts of protein (5 microg, 10 microg and 20 microg) were loaded onto the gel to ensure that the chemiluminescent signal changed in a linear manner. Primary and secondary antibody concentrations were also optimized.
###end p 22
###begin title 23
Statistical analyses
###end title 23
###begin p 24
###xml 159 166 159 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003738-t001">Table 1</xref>
###xml 683 684 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
Differences between individual baseline characteristics were analyzed by Student's t-test or non-parametrical tests (Wilcoxon, Mann-Whitney) when appropriate (Table 1). Nonparametric data were log transformed prior to testing and are shown as the % geometric mean basal control (95% confidence intervals). Parametric data are represented as % mean basal control+/-SEM. Differences in insulin stimulation between the two birth weight groups were analyzed using a two-way repeated measurement ANOVA with birth weight and insulin-stimulation as the independent variables, followed by Duncan's Post Hoc test when appropriate (Statistica 7.1, Statsoft, Tulsa, USA). For all data sets, a p-value <0.05 was considered statistically significant.
###end p 24
###begin title 25
Baseline Characteristics
###end title 25
###begin p 26
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
Differences between individual baseline characteristics were analyzed by Student's t-test, or non-parametrical tests (Wilcoxon, Mann-Whitney) when appropriate. p-value <0.05 was considered statistically significant.
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 26 33 26 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003738-t001">Table 1</xref>
Clinical characteristics (Table 1)
###end title 28
###begin p 29
###xml 31 35 31 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen2">[15]</xref>
###xml 55 58 55 58 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen1">[6]</xref>
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne1">[8]</xref>
###xml 229 231 229 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 212 215 <span type="species:ncbi:9606">men</span>
###xml 344 347 <span type="species:ncbi:9606">men</span>
###xml 684 687 <span type="species:ncbi:9606">men</span>
Demographic and metabolic data [15], fibre composition [6] and expression of select proteins in vastus lateralis muscle in the fasting state [8] have been reported previously. These studies showed that 19-yr old men with LBW (<10th percentile) had comparable current body weight, BMI, W/H-ratio, VO2max and total lean and fat mass with the NBW men, but were slightly shorter and had a tendency toward more central fat accumulation (as shown by the increased ratio of abdominal fat mass/total fat mass p<0.05). LBW was associated with a higher proportion of "glycolytic" type 2x (formerly 2b) fibres at the expense of fewer but larger "oxidative" type IIa fibres. In addition, the LBW men had slightly higher fasting plasma glucose and reduced insulin-stimulated whole-body glycolytic flux but normal whole-body glucose disposal, glucose oxidation, non-oxidative glucose metabolism and energy expenditure in the fasting and insulin-stimulated state.
###end p 29
###begin title 30
###xml 42 48 42 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1</xref>
###xml 53 60 53 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003738-t002">Table 2</xref>
Protein expression-basal (fasting) state (Fig. 1 and Table 2)
###end title 30
###begin p 31
###xml 164 172 154 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Figure 1</xref>
###xml 522 530 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Figure 1</xref>
###xml 535 542 525 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003738-t002">Table 2</xref>
Fasting expression of the PI3K p85alpha and p110beta subunits, PKCzeta and GLUT4 was reduced in LBW subjects when compared to controls, as previously reported (8) (Figure 1). Expression/phosphorylation of other proteins studied involved in metabolic pathway [(IRS1, Akt1, Akt2 and phospho-Akt (Ser 473)] or mitogenic pathway [p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182), JNK1, JNK2, phospho-JNK (Thr 183/Tyr185) and phospho-ERK (Thr202/Tyr204)] was unchanged in LBW subjects in fasting state in comparison to the controls [Figure 1 and Table 2].
###end p 31
###begin title 32
Expression and phosphorylation of key proteins involved in PI3K signalling.
###end title 32
###begin p 33
###xml 266 267 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 276 277 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 287 288 285 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Bars represent mean basal and insulin-stimulated (INS) expression values+/-SEM for low birth weight (LBW) and control (CON) individuals, expressed as % of mean control. Representative blots of the respective proteins are located below the corresponding bar graphs. *p<0.05, **p<0.01, ***p<0.001.
###end p 33
###begin title 34
Expression and phosphorylation of key proteins involved in MAPK-signalling.
###end title 34
###begin p 35
Values are presented as the geometric mean basal control [95% confidence limits] for p-ERK (Thr202/Tyr204) and p-p38 (Thr180/Tyr182) and as the % mean basal control+/-SEM for p38, p-JNK (Thr183/Tyr185), JNK1 and JNK2. Statistical differences were analysed using a repeated measures ANOVA. Data for p-ERK (Thr202/Tyr204) and p-p38 (Thr180/Tyr182) were log transformed prior to testing.
###end p 35
###begin title 36
###xml 45 51 45 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1</xref>
Protein expression-insulin-stimulated state (Fig. 1)
###end title 36
###begin title 37
(1) IRS1 and PI3K
###end title 37
###begin p 38
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 275 282 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1A</xref>
###xml 325 332 321 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1B</xref>
###xml 348 355 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1C</xref>
###xml 455 458 <span type="species:ncbi:9606">men</span>
Insulin infusion (4 hrs) per se did not lead to changes in expression of IRS1 in muscle of control subjects however LBW demonstrated enhanced expression for IRS-1 under insulin stimulated conditions (p<0.01) (interaction between birth weight and presence of insulin p<0.01) (Fig. 1A). Similarly, expression of PI3K p85alpha (Fig. 1B) and p110beta (Fig. 1C) did not change upon insulin infusion in controls but despite lower basal (fasting) expression LBW men had significantly increased p85alpha (p<0.001) and p110beta (p<0.001) after insulin infusion (interaction between birth weight and insulin infusion p<0.001 for both PI3K subunits). In addition the expression of both PI3K subunits was significantly increased in insulin stimulated LBW subjects in comparison to the insulin stimulated controls (for p85alpha p<0.001 and for p110beta p<0.05).
###end p 38
###begin title 39
(2) Akt
###end title 39
###begin p 40
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1D</xref>
###xml 318 325 318 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1E</xref>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1F</xref>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 230 233 <span type="species:ncbi:9606">men</span>
###xml 646 649 <span type="species:ncbi:9606">men</span>
There was an interaction between birth weight and insulin infusion on Akt1 expression (p<0.001). Insulin infusion significantly increased expression of Akt1 (p<0.001) in control subjects but it decreased expression of Akt1 in LBW men (p<0.05) (Fig. 1D). No differences were observed between groups in Akt2 expression (Fig. 1E). There was an interaction between birth weight and insulin infusion on phosphorylation of Akt at Ser 473 (p<0.05) (Fig. 1F). Insulin infusion significantly increased phosphorylation of Akt (Ser 473) in both control (p<0.001) and LBW groups (p<0.001), however the effect was greater in controls when compared to the LBW men (p<0.01).
###end p 40
###begin title 41
(3) PKCzeta and GLUT4
###end title 41
###begin p 42
###xml 258 265 252 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig. 1G</xref>
###xml 570 576 561 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003738-g001">Fig 1H</xref>
###xml 329 332 <span type="species:ncbi:9606">men</span>
###xml 634 637 <span type="species:ncbi:9606">men</span>
###xml 759 762 <span type="species:ncbi:9606">men</span>
There was an interaction between birth weight and insulin infusion on PKCzeta expression (p<0.001). Insulin infusion significantly increased expression of PKCzeta in control subjects (p<0.001), however no significant difference was observed in LBW subjects (Fig. 1G). There was significant reduction in PKCzeta expression in LBW men upon insulin stimulation when compared to insulin stimulated control subjects (p<0.001). Interestingly, insulin infusion had very different effect on GLUT4 expression. Insulin infusion lead to reduction in expression of GLUT4 (p<0.001) (Fig 1H) in controls, while significant increase occurred in LBW men (p<0.05). Despite lower basal (fasting) expression (p<0.01), insulin-stimulated expression of GLUT4 was increased in LBW men in comparison to controls (p<0.001). Interaction between birth weight and insulin stimulation on GLUT4 expression was significant (p<0.001).
###end p 42
###begin title 43
(4) Mitogenic proteins
###end title 43
###begin p 44
###xml 181 188 181 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0003738-t002">Table 2</xref>
There were no differences in the expression/phosphorylation of p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182), JNK1, JNK2, phospho-JNK (Thr 183/Tyr185) and phospho-ERK (Thr202/Tyr204) (Table 2).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 232 235 232 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne1">[8]</xref>
###xml 448 455 448 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 892 895 882 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Taniguchi1">[9]</xref>
###xml 897 901 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Farese1">[16]</xref>
###xml 66 69 <span type="species:ncbi:9606">men</span>
###xml 507 510 <span type="species:ncbi:9606">men</span>
We have previously shown that young and healthy, low birth weight men, exhibit multiple abnormalities in their skeletal muscle in the insulin signalling metabolic pathway downstream of the insulin receptor, under fasting conditions [8]. In this study we aimed to investigate whether any further alterations in either mitogenic (MAPK) or metabolic (PI3K/Akt) pathways downstream of insulin receptor can be detected in skeletal muscle in response to in vivo insulin stimulation that could explain why are LBW men at higher risk of developing insulin resistance and type 2 diabetes in later life. The main finding of this study is marked insulin-mediated up-regulation in LBW subjects of the PI3K p85alpha and p110beta subunits and reduced expression/phosphorylation of its two main effectors, PKCzeta and phospho-Akt at Ser 473, both of which are required for insulin-stimulated glucose uptake [9], [16].
###end p 46
###begin p 47
###xml 152 155 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne1">[8]</xref>
###xml 335 339 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne2">[17]</xref>
###xml 712 716 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Huang1">[18]</xref>
###xml 718 722 701 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Bouzakri1">[19]</xref>
###xml 924 928 907 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Bjornholm1">[20]</xref>
###xml 1177 1181 1160 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-RuizAlcaraz1">[21]</xref>
###xml 123 126 <span type="species:ncbi:9606">men</span>
###xml 806 809 <span type="species:ncbi:9606">men</span>
###xml 1008 1011 <span type="species:ncbi:9606">men</span>
Previously, we have reported reduced abundance of p85alpha, p110beta, PKCzeta and GLUT4 proteins in skeletal muscle of LBW men under fasting conditions [8]. Similar reductions of p85alpha, p110beta and GLUT4 were observed in subcutaneous abdominal fat biopsies from an independent LBW cohort, together with a marked reduction of IRS-1 [17]. IRS molecules are key mediators of insulin signalling and play a central role in maintaining basic cellular functions such as growth, survival and metabolism. Using siRNA (small interfering RNA)- mediated knockdown of IRS proteins, it was found that IRS-1, rather than IRS-2 is required for insulin-stimulated Akt1 phosphorylation, GLUT4 translocation and glucose uptake [18], [19]. Here we show that skeletal muscle IRS-1 expression was similar in control and LBW men. This is consistent with previous reports of normal IRS1 expression in the skeletal muscle from diabetic subjects [20]. We also show that insulin-stimulated expression of IRS-1 was increased in LBW men but not in controls. Recent studies in L6 myotubes showed that, prior to its down-regulation by degradation, IRS-1 protein is acutely induced by insulin stimulation [21]. Thus, the inappropriately increased IRS-1 in LBW at 4 h of insulin stimulation may be a consequence of delayed/protracted stimulation and/or delayed degradation.
###end p 47
###begin p 48
###xml 380 388 365 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 388 392 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ueki1">[22]</xref>
###xml 397 404 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 404 408 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-MauvaisJarvis1">[23]</xref>
###xml 535 539 516 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Bandyopadhyay1">[24]</xref>
###xml 628 632 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Barbour1">[25]</xref>
###xml 660 664 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Cornier1">[26]</xref>
###xml 845 846 822 823 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 859 863 836 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Luo1">[27]</xref>
Despite lower expression in the basal state, insulin stimulation increased expression of PI3K subunits p110beta and p85alpha in LBW subjects but not in controls. The mechanistic basis of this paradoxical increase following insulin infusion is unknown. Increased expression of p85alpha has been implicated in insulin resistance as knockout of p85alpha improves insulin sensitivity in vitro[22] and in vivo[23]. Conversely, over-expression of p85alpha is correlated with skeletal muscle insulin resistance in obesity and type 2 diabetes [24] and has been reported in insulin-resistant states induced by e.g. growth hormone excess [25] and short-term overfeeding [26]. It is thought that excess p85alpha may exert these effects by sequestration of IRS-1 and PI3K enzymatic activity into inert cellular foci incapable of PI-3, 4, 5-triphosphate (PIP3) generation [27].
###end p 48
###begin p 49
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Krook1">[28]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Cozzone1">[29]</xref>
###xml 503 507 503 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Kroook1">[30]</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Altomare1">[31]</xref>
###xml 735 739 735 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Altomare2">[32]</xref>
###xml 1005 1009 1005 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Cozzone1">[29]</xref>
###xml 1181 1184 1181 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Taniguchi1">[9]</xref>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Bouzakri2">[33]</xref>
###xml 498 502 <span type="species:ncbi:10116">rats</span>
###xml 1398 1401 <span type="species:ncbi:9606">men</span>
PI3K is thought to mediate many of its metabolic actions of insulin through phosphorylation of Akt. Phosphorylation of Akt at Ser473 was reduced in the LBW group compared to controls following insulin infusion, suggesting impaired PI3K activity. Limited sample availability meant that actual activity could not be determined. Decreased insulin stimulated Akt kinase activity has been previously reported in type 2 diabetic subject [28], [29] and non-obese spontaneously diabetic Goto-Kakizaki (GK) rats [30]. As well as a reduction in PI3K activity, reduced Akt1 expression could also contribute to reduction in phospho-Akt detected in the insulin stimulated LBW muscle. However, Akt2 is the prominent isoform in skeletal muscle [31], [32] thus phosphorylated Akt detected primarily represents phospho-Akt2. Our findings of no difference in the basal and insulin stimulated expression of Akt2 between control and LBW confirm previous finding that insulin stimulation has no effect on total Akt expression [29]. Knockout and siRNA studies have revealed that whereas Akt2 is indispensable for glucose homeostasis, Akt1 is essential for growth and may play a role in lipid metabolism [9], [33]. Decreased Akt1 levels in LBW may reflect a general resistance to stimulation by growth factors and combined with our findings in the basal state, could contribute to the reduced muscle mass observed in LBW men.
###end p 49
###begin p 50
###xml 273 277 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Kotani1">[34]</xref>
###xml 278 282 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Standaert1">[36]</xref>
###xml 483 487 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Bandyopadhyay2">[37]</xref>
###xml 489 493 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Bandyopadhyay3">[38]</xref>
###xml 547 554 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 616 620 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Etgen1">[39]</xref>
###xml 686 693 666 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 809 813 786 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Kim1">[40]</xref>
###xml 842 846 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Beeson1">[41]</xref>
###xml 864 868 841 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Kim1">[40]</xref>
###xml 870 874 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Beeson1">[41]</xref>
###xml 935 939 912 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Oak1">[42]</xref>
###xml 884 887 <span type="species:ncbi:10116">rat</span>
###xml 963 966 <span type="species:ncbi:9606">men</span>
In addition to decreased phosphorylation of phospho-Akt we have also found significant reduction in the expression of PKCzeta in LBW subjects. Activation of PKC isoforms lambda and zeta is required for GLUT4 translocation and glucose uptake in the insulin stimulated state [34]-[36]. This is supported by reports showing that over-expression of a dominant-negative mutant of PKCzeta in muscle cells leads to abrogation of insulin-stimulated glucose transport and GLUT4 translocation [37], [38], while over-expression of PKCzeta in skeletal muscle in vivo enhanced both basal and insulin-stimulated glucose transport [39]. The importance of PKCzeta in pathogenesis of insulin resistance in vivo has been suggested by numerous studies showing impaired activation of PKCzeta in skeletal muscle in obese subjects [40], impaired glucose tolerance [41], type 2 diabetes [40], [41] and in a rat model of intrauterine growth restriction (IUGR)[42]. Here we show that LBW men have diminished basal and insulin stimulated expression of PKCzeta, which would provide less substrate for full activation.
###end p 50
###begin p 51
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Andersen1">[43]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Handberg1">[44]</xref>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Andersen1">[43]</xref>
###xml 447 451 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Handberg1">[44]</xref>
###xml 582 585 582 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Ozanne1">[8]</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Thamotharan1">[45]</xref>
###xml 887 891 887 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Thamotharan1">[45]</xref>
###xml 113 116 <span type="species:ncbi:9606">men</span>
###xml 279 282 <span type="species:ncbi:9606">men</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 575 581 <span type="species:ncbi:9606">humans</span>
###xml 620 623 <span type="species:ncbi:10116">rat</span>
GLUT4 levels, despite being lower under basal conditions were paradoxically increased by insulin infusion in LBW men. Thus, while insulin-stimulation reduced total GLUT4 in the control subjects, consistent with two previous reports [43], [44], no such effect was observed in LBW men. Interestingly, a similar lack of response to insulin was also observed in type 2 diabetes patients [43] and following insulin resistance induced by lipid infusion [44], indicating that this phenomenon may indeed be related to insulin resistance. Consistent with our previous observations in humans [8], it was recently shown that adult rat IUGR offspring have reduced GLUT4 abundance in muscle in the basal state [45]. Moreover, redistribution of GLUT4 from intracellular compartments to the plasma membrane in the basal state was partly responsible for a total inability of GLUT4 to respond to insulin [45]. Thus, it is possible that the higher insulin-stimulated GLUT4 protein levels observed in our LBW subjects do not translate into increased GLUT4 translocation and improved glucose disposal.
###end p 51
###begin p 52
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Koistinen1">[10]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Huang2">[46]</xref>
###xml 766 769 766 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003738-Jensen1">[6]</xref>
###xml 88 96 <span type="species:ncbi:9606">patients</span>
###xml 352 355 <span type="species:ncbi:9606">men</span>
###xml 762 765 <span type="species:ncbi:9606">men</span>
###xml 854 862 <span type="species:ncbi:9606">patients</span>
Following reports of aberrant p38 MAPK signalling in skeletal muscle of type 2 diabetic patients [10] and increased phosphorylation and activity of p38 MAPK upon hyperglycaemia in cultured L6 myotubes [46] we decided to asses whether insulin action upon mitogenic signalling pathway can be also implicated in the pathogenesis of type 2 diabetes in LBW men. Insulin stimulated expression/phosphorylation of all the MAPK proteins studied p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182), phospho-ERK (Thr 202/Tyr204), JNK1, JNK2 and phospho-JNK (Thr 183/Tyr185) was not different between NBW and LBW groups studied. Therefore we can conclude that key proteins involved in MAPK signalling pathway do not contribute to alterations observed in skeletal muscle of young LBW men [6]. It is possible that the changes reported in p38 MAPK signalling in type 2 diabetic patients are a consequence of diabetes and may develop in LBW as their glucose homeostasis deteriorates.
###end p 52
###begin p 53
###xml 219 226 219 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 324 325 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In summary, we have demonstrated that LBW, a known risk factor for development of insulin resistance and type 2 diabetes, is associated with multiple defects in the PI3K/Akt pathway under basal conditions and following in vivo insulin-stimulation. Given that these were young healthy subjects, matched for total body fat, VO2max and whole-body insulin sensitivity, we speculate that these are primary defects, likely to contribute to the pathogenesis of skeletal muscle loss and development of muscle insulin resistance associated with LBW. Prospective studies are needed to establish the significance and/or reversibility of these findings.
###end p 53
###begin p 54
###xml 44 49 <span type="species:ncbi:9606">human</span>
We wish to express our gratitude to all the human volunteers without whom this study would not have been possible.
###end p 54
###begin title 55
References
###end title 55
###begin article-title 56
Early life events and their consequences for later disease: a life history and evolutionary perspective.
###end article-title 56
###begin article-title 57
Developmental origins of the metabolic syndrome: prediction, plasticity, and programming.
###end article-title 57
###begin article-title 58
Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.
###end article-title 58
###begin article-title 59
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study.
###end article-title 59
###begin article-title 60
Fetal programming of body composition: relation between birth weight and body composition measured with dual-energy X-ray absorptiometry and anthropometric methods in older Englishmen.
###end article-title 60
###begin article-title 61
###xml 98 101 <span type="species:ncbi:9606">Men</span>
Altered Skeletal Muscle Fiber Composition and Size Precede Whole-body Insulin Resistance in Young Men with Low Birth Weight.
###end article-title 61
###begin article-title 62
Normal insulin-stimulated endothelial function and impaired insulin-stimulated muscle glucose uptake in young adults with low birth weight.
###end article-title 62
###begin article-title 63
Low birthweight is associated with specific changes in muscle insulin-signalling protein expression.
###end article-title 63
###begin article-title 64
Critical nodes in signalling pathways: insights into insulin action.
###end article-title 64
###begin article-title 65
###xml 97 105 <span type="species:ncbi:9606">patients</span>
Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from Type 2 diabetic patients.
###end article-title 65
###begin article-title 66
Activation and signaling of the p38 MAP kinase pathway.
###end article-title 66
###begin article-title 67
Activation of cJun NH2-terminal kinase/stress-activated protein kinase by insulin.
###end article-title 67
###begin article-title 68
Activation of the glucose transporter GLUT4 by insulin.
###end article-title 68
###begin article-title 69
C-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade.
###end article-title 69
###begin article-title 70
###xml 85 88 <span type="species:ncbi:9606">men</span>
Early differential defects of insulin secretion and action in 19-year- old Caucasian men who had low birth weight.
###end article-title 70
###begin article-title 71
Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes.
###end article-title 71
###begin article-title 72
###xml 90 93 <span type="species:ncbi:9606">men</span>
Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight-potential link to increased risk of diabetes?
###end article-title 72
###begin article-title 73
Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in l6 myotubes.
###end article-title 73
###begin article-title 74
###xml 117 122 <span type="species:ncbi:9606">human</span>
siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle.
###end article-title 74
###begin article-title 75
Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation.
###end article-title 75
###begin article-title 76
A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration.
###end article-title 76
###begin article-title 77
Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling.
###end article-title 77
###begin article-title 78
###xml 26 32 <span type="species:ncbi:10090">murine</span>
Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
###end article-title 78
###begin article-title 79
###xml 105 110 <span type="species:ncbi:9606">human</span>
Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle.
###end article-title 79
###begin article-title 80
Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
###end article-title 80
###begin article-title 81
Nutritional upregulation of p85alpha expression is an early molecular manifestation of insulin resistance.
###end article-title 81
###begin article-title 82
The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex.
###end article-title 82
###begin article-title 83
Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects.
###end article-title 83
###begin article-title 84
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.
###end article-title 84
###begin article-title 85
###xml 144 148 <span type="species:ncbi:10116">rats</span>
Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats.
###end article-title 85
###begin article-title 86
Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin.
###end article-title 86
###begin article-title 87
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene.
###end article-title 87
###begin article-title 88
###xml 117 122 <span type="species:ncbi:9606">human</span>
siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle.
###end article-title 88
###begin article-title 89
Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes.
###end article-title 89
###begin article-title 90
Repletion of Atypical Protein Kinase C following RNA Interference-mediated Depletion Restores Insulin-stimulated Glucose Transport.
###end article-title 90
###begin article-title 91
###xml 110 113 <span type="species:ncbi:10116">rat</span>
Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes: potential role in glucose transport.
###end article-title 91
###begin article-title 92
Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes.
###end article-title 92
###begin article-title 93
Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes.
###end article-title 93
###begin article-title 94
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 112 115 <span type="species:ncbi:10116">rat</span>
In vivo adenoviral delivery of recombinant human protein kinase C-zeta stimulates glucose transport activity in rat skeletal muscle.
###end article-title 94
###begin article-title 95
###xml 90 96 <span type="species:ncbi:9606">humans</span>
Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction.
###end article-title 95
###begin article-title 96
Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
###end article-title 96
###begin article-title 97
###xml 95 98 <span type="species:ncbi:10116">rat</span>
Perturbed skeletal muscle insulin signaling in the adult female intrauterine growth-restricted rat.
###end article-title 97
###begin article-title 98
###xml 124 132 <span type="species:ncbi:9606">patients</span>
Expression of the major insulin regulatable glucose transporter (GLUT4) in skeletal muscle of noninsulin-dependent diabetic patients and healthy subjects before and after insulin infusion.
###end article-title 98
###begin article-title 99
###xml 63 66 <span type="species:ncbi:9606">man</span>
Peripheral glucose uptake and skeletal muscle GLUT4 content in man: effect of insulin and free fatty acids.
###end article-title 99
###begin article-title 100
###xml 90 93 <span type="species:ncbi:10116">rat</span>
GLUT4 expression and subcellular localization in the intrauterine growth-restricted adult rat female offspring.
###end article-title 100
###begin article-title 101
Sustained exposure of L6 myotubes to high glucose and insulin decreases insulin-stimulated GLUT4 translocation but upregulates GLUT4 activity.
###end article-title 101
###begin p 102
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 102
###begin p 103
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Generous funding was provided by The Danish Diabetes Association, The British Heart Foundation, AP Moller Foundation for the Advancement of Science, Laegeforeningens Forskningsfond, IMK Almene Fond, The Parthenon Trust, Augustinus Fonden, The Danish Strategic Research Council and Arvid Nilssons Fond. This work was carried out in the Steno Diabetes Centre, University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.
###end p 103

